|
Catastrophes after
crossing species barriers
Thursday 6th May: Scientists attending the 14th European Congress of
Clinical Microbiology & Infectious Diseases (ECCMID) in
Prague
were told that conventional medical textbooks were not to be trusted by
Professor Albert Osterhaus of
Erasmus
University
,
Rotterdam
. He described the alarming
trends seen in the last 20 years caused by more emerging viruses
crossing species barriers - going against all currently held dogma.
When the symptoms of SARS first emerged, scientists believed it to be a
new pandemic flu outbreak. But
under the auspices of the WHO, and following unprecedented collaboration
between laboratories worldwide, SARS was eventually identified as a
novel coronavirus whose natural reservoir is now believed to be the
civet cats traded in the wild animal markets of
Southern China
.
However, SARS is now recognised to be only the latest one of a number of
respiratory viruses that have been shown to cross the species barriers.
Professor Osterhaus also described how the influenza A virus has
a unique ability to reassort leading to the mutation of the low
pathogenic virus in the wild bird and poultry population into highly
virulent forms affecting poultry, domestic animals and humans.
Dr Ron Fouchier of
Erasmus
University
,
Rotterdam
added, "Avian flu is now affecting humans much more frequently.
Last year in the
Netherlands
there were 89 cases with only one fatality.
This year to date we have seen 3 cases in N. America and 34 in SE
Asia - with 23 fatalities. In
SE Asia
, these cases could be the tip of the iceberg.
If we look we might find many more cases."
In the
Netherlands
there is now a policy of active surveillance of poultry to find the
carriers before the virus mutates.
The Nipah and Hendra viruses have re-emerged in
SE Asia
,
Australia
and the Indian subcontinent, with possibly a first case of direct
transmission from fruit bat host to human, and
West Nile
virus now affects virtually the whole of the North American bird
population.
Professor Osterhaus firmly believes that such catastrophes will continue
to occur and pose a serious threat to public health in the future due to
a complex mix of societal, technological, ecological and viral changes.
To address this we must develop extensive diagnostic and
surveillance networks as well as novel vaccines and antiviral therapy
and protection strategies. It
will also be vital for laboratories worldwide to adopt the unique SARS
cooperation model. All this
should provide the safeguards to limit their impact.
(26/5/04) |